Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: A prospective serial study

被引:75
作者
Yue-Xi Zhang [1 ]
Li-Ya Zhou [2 ]
Zhi-Qiang Song [2 ]
Jian-Zhong Zhang [3 ]
Li-Hua He [3 ]
Yu Ding [2 ]
机构
[1] Department of Gastroenterology,Beijing Sixth Hospital
[2] Department of Gastroenterology,Peking University Third Hospital
[3] State Key Laboratory for Infectious Disease Prevention and Control,National Institute for Communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention
关键词
Helicobacter pylori; Antibiotic resistance; Beijing; Dyspeptic symptoms;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM:To determine the resistance patterns of Helicobacter pylori(H.pylori) strains isolated from patients in Beijing and monitor the change of antibiotic resistance over time.METHODS:In this prospective,serial and crosssectional study,H.pylori cultures were successfully obtained from 371 and 950 patients(never receiving eradication) during 2009-2010 and 2013-2014,respectively.Resistance to amoxicillin,clarithromycin,metronidazole,levofloxacin,tetracycline,and rifampicin was determined by Epsilometer test.RESULTS:The resistance rates of isolates obtained during 2009-2010 were 66.8%,39.9%,34.5%,15.4%,6.7%,and 4.9% to metronidazole,clarithromycin,levofloxacin,rifampicin,amoxicillin and tetracycline,respectively; and the corresponding rates for isolates during 2013-2014 were 63.4%,52.6%,54.8%,18.2%,4.4% and 7.3%,respectively.The resistance rates to clarithromycin and levofloxacin were significantly increased after four years.In 2009-2010,14.6% of H.pylori isolates were susceptible to all tested antibiotics,with mono(33.7%),double(28.3%),triple(16.7%),quadruple(6.2%),quintuple(0.3%) and sextuple resistance(0.3%) also being detected.In 2013-2014,9.4% were susceptible to all tested antibiotics,and mono(27.6%),double(28.4%),triple(24.9%),quadruple(7.3%),quintuple(2.3%) and sextuple resistance(0.1%) was also observed.More multiple resistant H.pylori isolates were found during 2013-2014.Gender(to levofloxacin and metronidazole),age(to levofloxacin) and endoscopic findings(to clarithromycin) were independent factors influencing antibiotic resistance.CONCLUSION:H.pylori resistance to commonly used antibiotics in Beijing is high with increased multiple antibiotic resistance.
引用
收藏
页码:2786 / 2792
页数:7
相关论文
共 13 条
[1]   Helicobacter pylori therapy:Present and future [J].
Vincenzo De Francesco ;
Enzo Ierardi ;
Cesare Hassan ;
Angelo Zullo .
World Journal of Gastrointestinal Pharmacology and Therapeutics, 2012, (04) :68-73
[2]   北京地区幽门螺杆菌耐药情况及其变化趋势 [J].
成虹 ;
胡伏莲 .
中华医学杂志, 2005, (39) :23-26
[3]  
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy[J] . Luigi Gatta,Nimish Vakil,Dino Vaira,Carmelo Scarpignato.BMJ . 2013 (aug0)
[4]   Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection [J].
Liu, Wen Zhong ;
Xie, Yong ;
Cheng, Hong ;
Lu, Nong Hua ;
Hu, Fu Lian ;
Zhang, Wan Dai ;
Zhou, Li Ya ;
Chen, Ye ;
Zeng, Zhi Rong ;
Wang, Chong Wen ;
Xiao, Shu Dong ;
Pan, Guo Zong ;
Hu, Pin Jin .
JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (05) :211-221
[5]   Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection [J].
Federico, Alessandro ;
Nardone, Gerardo ;
Gravina, Antonietta G. ;
Iovene, Maria Rosaria ;
Miranda, Agnese ;
Compare, Debora ;
Pilloni, Paola A. ;
Rocco, Alba ;
Ricciardiello, Luigi ;
Marmo, Riccardo ;
Loguercio, Carmelina ;
Romano, Marco .
GASTROENTEROLOGY, 2012, 143 (01) :55-U563
[6]  
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori : a multicentre, open-label, randomised trial[J] . Jyh-Ming Liou,Chieh-Chang Chen,Mei-Jyh Chen,Chien-Chuan Chen,Chi-Yang Chang,Yu-Jen Fang,Ji–Yuh Lee,Shih-Jer Hsu,Jiing-Chyuan Luo,Wen-Hsiung Chang,Yao-Chun Hsu,Cheng-Hao Tseng,Ping-Huei Tseng,Hsiu-Po Wang,Ueng-Cheng Yang,Chia-Tung Shun,Jaw-Town Lin,Yi-Chia Lee,Ming-Shiang Wu.The Lancet . 2012
[7]  
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori[J] . Javier Gisbert,Calvet.Clinical and Experimental Gastroenterology . 2012 (defa)
[8]   Primary Antibiotic Resistance of Helicobacter pylori Isolated from Beijing Children [J].
Liu, Guodong ;
Xu, Xiwei ;
He, Lihua ;
Ding, Zhaolu ;
Gu, Yixin ;
Zhang, Jianzhong ;
Zhou, Liya .
HELICOBACTER, 2011, 16 (05) :356-362
[9]   Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection [J].
Wu, Deng-Chyang ;
Hsu, Ping-I ;
Wu, Jeng-Yih ;
Opekun, Antone R. ;
Kuo, Chao-Hung ;
Wu, I-Chen ;
Wang, Sophie S. W. ;
Chen, Angela ;
Hung, Wen-Chun ;
Graham, David Y. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (01) :36-41
[10]   Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection [J].
Furuta, Takahisa ;
Graham, David Y. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2010, 39 (03) :465-+